Filing Details

Accession Number:
0001214659-15-007104
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-13 20:02:58
Reporting Period:
2015-10-12
Filing Date:
2015-10-13
Accepted Time:
2015-10-13 20:02:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1316175 Anthera Pharmaceuticals Inc ANTH Pharmaceutical Preparations (2834) 201852016
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1281719 Debra Odink 25801 Industrial Blvd Suite B
Hayward CA 94545
Chief Technology Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-10-12 1,205 $6.15 7,896 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13,855 Indirect By Trust
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2015.